Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

MEBCAVIR 200 - MOLNUPIRAVIR 200 MG CAPSULES
Connect with this vendor - Learn about this product

MEBCAVIR 200 - Molnupiravir 200 mg Capsules

MEBCAVIR 200

 

Medicine composition: Molnupiravir 200 mg Capsules

Dosage Form: Capsules

Packing: 40 Capsules

Market Authorization: MBA Pharmaceuticals Pvt Ltd

Country Of Origin: India

Similar to Molnatris

MEBCAVIR is indicated for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults with a positive SARS-COV-2 diagnostic test and who have at least one risk factor for developing severe illness.